XJ101
/ Starmab Biologics
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 14, 2024
A Phase I Study of XJ101 in Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=38 | Active, not recruiting | Sponsor: Starmab biologics（Shanghai）Co,.ltd | Trial completion date: Apr 2024 ➔ Sep 2024
Trial completion date • Infectious Disease
January 11, 2024
A Phase I Study of XJ101 in Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=38 | Active, not recruiting | Sponsor: Starmab biologics（Shanghai）Co,.ltd | Not yet recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease
August 28, 2023
A Phase I Study of XJ101 in Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=38 | Not yet recruiting | Sponsor: Starmab biologics（Shanghai）Co,.ltd
New P1 trial • Infectious Disease
1 to 3
Of
3
Go to page
1